Genus Capital Management Inc. Novo Nordisk A S Put Options Transaction History

Genus Capital Management Inc.

  • $763 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Oct 29, 2024
SELL
$119.07 - $145.42 $191,464 - $233,835
-1,608 Reduced 11.54%
12,321 $1.47 Billion
Q2 2024

Aug 09, 2024
BUY
$122.71 - $146.91 $1.71 Million - $2.05 Million
13,929 New
13,929 $1.99 Billion
Q4 2023

Feb 06, 2024
BUY
$87.78 - $105.45 $1.56 Million - $1.88 Million
17,782 New
17,782 $1.84 Billion

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Genus Capital Management Inc. Portfolio

Follow Genus Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Genus Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Genus Capital Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email